Navigation Links
Keryx Biopharmaceuticals, Inc. To Host Conference Call on Second Quarter 2012 Financial Results
Date:8/6/2012

NEW YORK, Aug. 6, 2012 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease, today announced that a conference call will be held on Wednesday, August 8, 2012 at 8:30 a.m. EDT to discuss results for the second quarter ended June 30, 2012 and a business outlook for the remainder of 2012. Ron Bentsur, Chief Executive Officer of Keryx, will host the call.

In order to participate in the conference call, please call 1-877-869-3847 (U.S.), 1-201-689-8261 (outside the U.S.), call-in ID: KERYX. The audio recording of the conference call will be available for replay at http://www.keryx.com, for a period of 15 days after the call.

Keryx will announce its financial results for this period in a press release to be issued prior to the call.

ABOUT KERYX BIOPHARMACEUTICALS, INC.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease. Keryx is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. The Phase 3 clinical program of Zerenex for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is being conducted pursuant to a Special Protocol Assessment (SPA) agreement with the FDA. Keryx is headquartered in New York City. 

KERYX CONTACT:
Lauren Fischer
Director - Investor Relations
Keryx Biopharmaceuticals, Inc.
Tel: 212.531.5965
E-mail: lfischer@keryx.com


'/>"/>
SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
2. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
3. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
4. Savient Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
5. Sinovac to Host Conference Call to Report Second Quarter 2012 Unaudited Financial Results
6. American Pacific To Release Financial Results And Hold Fiscal 2012 Third Quarter Investor Teleconference
7. Pro-Dex, Inc. Announces Update Conference Call and Webcast
8. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
9. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2012 Financial Results on August 9, 2012
10. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
11. Winner Medical Group Inc. to Host Third Quarter 2012 Earning Conference Call on Thursday, August 9, 2012 at 09:00 p.m. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)...  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ), a specialty ... innovative therapies for the treatment of acute and breakthrough ... chief financial officer  will be participating in three upcoming ... Mizuho Third Annual Healthcare Corporate Access Day ... New York Bank ...
(Date:4/30/2015)... April 30, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. ... with a focus on Omega-3 therapies for cardiovascular ... highlights and financial results for the fiscal year ... herein are in Canadian dollars unless otherwise stated. ... significant, with the right strategic partners and additional ...
(Date:4/30/2015)... April 30, 2015  Accuray Incorporated (Nasdaq: ... an agreement with MIM Software Inc. to further ... and CyberKnife ® product portfolios. The new ... technology. This is Accuray,s second collaboration with MIM; ... the first iPad-based treatment plan review capability, PlanTouch™. ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May 2Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 3
... COLD SPRING HARBOR, N.Y. , May 18 AccuVein ... Medipath Division of Morepen Laboratories to sell the AV300 vein finder in ... signed 30 distributors worldwide. , , ... AccuVein AV300 helps healthcare professionals locate veins for blood draw , ...
... , WINTER PARK, Fla. , May 18 ... cataract surgery and presbyopia, today announced that the company has received ... System for anterior capsulotomy during cataract surgery.   , ... The LensAR Laser System integrates ...
Cached Medicine Technology:AccuVein Signs Exclusive Distribution Agreement in India to Sell Vein Illumination Device 2AccuVein Signs Exclusive Distribution Agreement in India to Sell Vein Illumination Device 3LensAR Laser System(TM) Receives FDA Clearance for Use in Cataract Surgery 2
(Date:5/1/2015)... Providenciales, Turks and Caicos Islands, BWI (PRWEB) May 02, ... has a new website! It is http://www.thevenetiangracebay.com ... resort itself, and it incorporates the stunning white and ... "According to a study of Google, sixty seven percent ... process. The study showed that smartphones were used ...
(Date:5/1/2015)... 2015 Jusuru International has been awarded ... repositioning of its flagship nutritional supplement, Liquid BioCell™ Life, ... new name, new logo, new packaging, new products, and ... designed to identify and promote programs that serve as ... “DSA congratulates Jusuru International for their outstanding accomplishments and ...
(Date:5/1/2015)... 2015 The Workgroup for Electronic ... on the use of health IT to create efficiencies ... resource to the United States Government Accountability Office (GAO) ... cards in Medicare. The report, “ Potential Uses of ... released to the public on Apr. 24, 2015 and ...
(Date:5/1/2015)... 01, 2015 It’s raining bills on Capitol ... proposals to expand federal support for telemedicine. , ... has been working with Congress,” said Jonathan Linkous, CEO of ... the nation is poised to embrace the use of telecommunications ... step in fulfilling ATA’s mission to improve quality, access, equity ...
(Date:5/1/2015)... KY (PRWEB) May 01, 2015 Ernst ... CEO, Dr. Joshua Rosenthal, Co-Founder & CSO, and Burak ... finalists for the EY Entrepreneur Of The Year® ... Ernst & Young is a global leader in ... to be one of the top audit companies ...
Breaking Medicine News(10 mins):Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2
... -- The worldwide incidence of cancer is expected to increase ... than 90 percent in the poorest nations, a new study ... cervical and stomach cancer) appear to be declining in some ... by substantial increases in the types of cancer associated with ...
... , THURSDAY, May 31 (HealthDay News) -- More than ... new government report shows. "Untreated tooth decay is ... Dye, an epidemiologist at the U.S. Centers for Disease ... appears that we haven,t been able to make any ...
... Four University of Houston (UH) students are well on their ... this spring in their work toward new therapies for prostate ... Center for Nuclear Receptors and Cell Signaling (CNRCS), these students ... and expressed, which is vital in developing treatments for cancer. ...
... Philadelphia National data show that currently more than ... obese, and an additional 10 percent are overweight. In ... School of Medicine at the University of Pennsylvania, in ... says that effective strategies to target pregnancy, infancy, and ...
... icon of cleanliness for home and commercial kitchens, restaurants, ... bacteria like other surfaces if not cleaned often. Scientists ... Langmuir , of a practical way to make stainless ... explain that while stainless steel is prized for its ...
... THURSDAY, May 31 (HealthDay News) -- When men are ... their future fertility than women, new Scottish research says. ... information provided to young women diagnosed with cancer and ... fertility expert," study co-author Valerie Peddie, a fertility nurse ...
Cached Medicine News:Health News:Worldwide Cancer Incidence Predicted to Rise 75% by 2030 2Health News:1 in 5 Americans Has Untreated Cavities: CDC 2Health News:Student researchers seek to develop new therapies for cancer 2Health News:Student researchers seek to develop new therapies for cancer 3Health News:Researchers call for obesity prevention efforts to focus on community-wide systems 2Health News:Men and Women With Cancer May Receive Different Fertility Information 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: